KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to -$247.0 million.

  • Quest Diagnostics' Cash from Financing Activities fell 11395.48% to -$247.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 19183.53%. This contributed to the annual value of $1.1 billion for FY2024, which is 57750.0% up from last year.
  • As of Q3 2025, Quest Diagnostics' Cash from Financing Activities stood at -$247.0 million, which was down 11395.48% from -$293.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Cash from Financing Activities registered a high of $1.8 billion during Q3 2024, and its lowest value of -$1.6 billion during Q2 2021.
  • For the 5-year period, Quest Diagnostics' Cash from Financing Activities averaged around -$217.3 million, with its median value being -$247.0 million (2025).
  • In the last 5 years, Quest Diagnostics' Cash from Financing Activities crashed by 114736.84% in 2022 and then surged by 223253.01% in 2024.
  • Quarter analysis of 5 years shows Quest Diagnostics' Cash from Financing Activities stood at -$369.0 million in 2021, then crashed by 47.7% to -$545.0 million in 2022, then soared by 123.85% to $130.0 million in 2023, then tumbled by 230.77% to -$170.0 million in 2024, then crashed by 45.29% to -$247.0 million in 2025.
  • Its Cash from Financing Activities was -$247.0 million in Q3 2025, compared to -$293.0 million in Q2 2025 and -$561.0 million in Q1 2025.